IIM
TVGN icon

INTECH Investment Management’s Tevogen Bio Holdings TVGN Stock Holding History

INTECH Investment Management’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-251
Closed -$4.16K – 2377
2025
Q4 		$4.16K Sell
251
-34
-12% -$884 ﹤0.01% 2310
2025
Q3 		$11.2K Sell
285
-67
-19% -$3.29K ﹤0.01% 2400
2025
Q2 		$22K Buy
352
+42
+14% +$2.39K ﹤0.01% 2447
2025
Q1 		$16.7K Buy
310
+87
+39% +$5.72K ﹤0.01% 2510
2024
Q4 		$11.5K Buy
+223
New +$14.5K ﹤0.01% 2377

Other funds holding TVGN

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

INTECH Investment Management's TVGN Position: Q1 2026 in Review

INTECH Investment Management sold out of Tevogen Bio Holdings (TVGN) in Q1 2026, closing a stake of 251 shares — an estimated $4.16K sold.

INTECH Investment Management first reported a position in TVGN in Q4 2024 and held it in 5 quarters. The position peaked at $22K in Q2 2025. 30 funds tracked by Wall St. Rank hold TVGN as of Q1 2026.

  • INTECH Investment Management reported no remaining Tevogen Bio Holdings position as of Q1 2026 after selling out during the quarter.
  • INTECH Investment Management sold 251 Tevogen Bio Holdings shares in Q1 2026, an estimated $4.16K.
  • INTECH Investment Management first reported a position in Tevogen Bio Holdings in Q4 2024 and held it in 5 quarters.
  • INTECH Investment Management's Tevogen Bio Holdings position peaked at $22K in Q2 2025.
  • 30 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.